The current PROG market cap is 7.9M. The company's latest EPS is USD -4.2739 and P/E is -0.14.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 80k | 14k | 2k | 2k | 0 |
Operating Income | -13.89M | -13.78M | -15.54M | -14.93M | -23.32M |
Net Income | -5.11M | -13.72M | -17.44M | -17.81M | -73.45M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 127.97M | 143.99M | 74.31M | 1.25M | 305k |
Operating Income | -116.57M | -140.12M | -195.19M | -117.84M | -61.78M |
Net Income | -129.11M | -228.83M | -192.8M | -247.41M | -38.16M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 62.61M | 53.53M | 53.24M | 49.67M | 34.7M |
Total Liabilities | 160.06M | 155.81M | 158.24M | 170.55M | 153.49M |
Total Equity | -97.44M | -102.29M | -105M | -120.88M | -118.79M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 116.4M | 101.73M | 154.44M | 108.84M | 53.53M |
Total Liabilities | 153.37M | 185.6M | 261.43M | 193.82M | 155.81M |
Total Equity | -36.97M | -83.87M | -106.99M | -84.98M | -102.29M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -53.4M | -64.42M | -12.1M | -23.72M | -34.75M |
Investing | -720k | -792k | -6k | -25k | -26k |
Financing | 2.78M | 7.3M | 12.08M | 19.71M | 16.86M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -65.13M | -106.12M | -165.74M | -167.49M | -64.42M |
Investing | 55.83M | 16.53M | -4.94M | -1.24M | -792k |
Financing | -12.81M | 73.64M | 229.72M | 165.05M | 7.3M |
Market Cap | 7.9M |
Price to Earnings Ratio | -0.14 |
Price to Sales Ratio | 17.84 |
Price to Cash Ratio | 0.18 |
Price to Book Ratio | -0.05 |
Dividend Yield | - |
Shares Outstanding | 8.93M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.01 (0.62%) |
Company Name | Biora Therapeutics Inc |
Address |
850 new burton road dover, delaware 19904 |
Website | https://www.bicara.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.